| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.18 | 0.008 |